Q4 2017
Released Feb 26, 2018, before the open
10-K filed Feb 26, 2018, 57 days after period end · 0001493152-18-002569
Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.30M$1.30M derived+74.3% vs Q4 2016+41.9% vs Q3 2017
Net Income$1.29M$1.29M derivedN/M vs Q4 2016N/M vs Q3 2017
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$788,000+104.1%
Operating Incomederived-$403,000N/M
Operating Cash Flowderived$1,794,000N/M
Margins · derived
Gross margin60.6%+8.9 pt vs Q4 2016
Operating margin-31.0%+50.6 pt vs Q4 2016
Net margin99.2%+187.0 pt vs Q4 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.30M | $746.00K | $513.00K | $343.00K |
| Net Income | $1.29M | -$655.00K | -$935.00K | -$1.24M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR